HEADER TRANSFERASE/TRANSFERASE INHIBITOR 29-AUG-15 5DH3 TITLE CRYSTAL STRUCTURE OF MST2 IN COMPLEX WITH XMU-MP-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MAMMALIAN STE20-LIKE PROTEIN KINASE 2,MST-2,STE20-LIKE COMPND 5 KINASE MST2,SERINE/THREONINE-PROTEIN KINASE KRS-1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STK3, KRS1, MST2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-28A KEYWDS MST2, MST1, HIPPO PATHWAY, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.L.KONG,C.H.YUN REVDAT 3 08-NOV-23 5DH3 1 REMARK REVDAT 2 27-SEP-17 5DH3 1 REMARK REVDAT 1 31-AUG-16 5DH3 0 JRNL AUTH F.FAN,Z.HE,L.L.KONG,Q.CHEN,Q.YUAN,S.ZHANG,J.YE,H.LIU,X.SUN, JRNL AUTH 2 J.GENG,L.YUAN,L.HONG,C.XIAO,W.ZHANG,X.SUN,Y.LI,P.WANG, JRNL AUTH 3 L.HUANG,X.WU,Z.JI,Q.WU,N.S.XIA,N.S.GRAY,L.CHEN,C.H.YUN, JRNL AUTH 4 X.DENG,D.ZHOU JRNL TITL PHARMACOLOGICAL TARGETING OF KINASES MST1 AND MST2 AUGMENTS JRNL TITL 2 TISSUE REPAIR AND REGENERATION JRNL REF SCI TRANSL MED V. 8 RA108 2016 JRNL REFN ESSN 1946-6242 JRNL PMID 27535619 JRNL DOI 10.1126/SCITRANSLMED.AAF2304 REMARK 2 REMARK 2 RESOLUTION. 2.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.22 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 26636 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1342 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.2253 - 5.3144 1.00 2686 151 0.1935 0.2240 REMARK 3 2 5.3144 - 4.2190 1.00 2607 127 0.1661 0.1859 REMARK 3 3 4.2190 - 3.6860 1.00 2565 134 0.1763 0.1949 REMARK 3 4 3.6860 - 3.3490 1.00 2565 121 0.2103 0.2374 REMARK 3 5 3.3490 - 3.1091 1.00 2534 152 0.2406 0.3024 REMARK 3 6 3.1091 - 2.9258 1.00 2525 134 0.2671 0.3079 REMARK 3 7 2.9258 - 2.7793 1.00 2526 138 0.2671 0.3371 REMARK 3 8 2.7793 - 2.6583 0.99 2504 128 0.2883 0.3270 REMARK 3 9 2.6583 - 2.5560 0.99 2511 136 0.2962 0.3539 REMARK 3 10 2.5560 - 2.4678 0.90 2271 121 0.3033 0.3571 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4700 REMARK 3 ANGLE : 1.044 6389 REMARK 3 CHIRALITY : 0.075 718 REMARK 3 PLANARITY : 0.012 804 REMARK 3 DIHEDRAL : 21.717 1823 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5DH3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1000213194. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL18U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97861 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26735 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.45200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4LG4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS PH 6.5, 28% PEG3350, REMARK 280 0.2M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.38550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 83.38550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.93550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 49.23100 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.93550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 49.23100 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 83.38550 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.93550 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 49.23100 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 83.38550 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 44.93550 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 49.23100 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 556 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 HIS A 1 REMARK 465 MET A 2 REMARK 465 ALA A 3 REMARK 465 SER A 4 REMARK 465 MET A 5 REMARK 465 THR A 6 REMARK 465 GLY A 7 REMARK 465 GLY A 8 REMARK 465 GLN A 9 REMARK 465 GLN A 10 REMARK 465 MET A 11 REMARK 465 GLY A 12 REMARK 465 ARG A 13 REMARK 465 GLY A 14 REMARK 465 SER A 15 REMARK 465 GLU A 16 REMARK 465 ASP A 17 REMARK 465 SER A 18 REMARK 465 GLU A 308 REMARK 465 LEU A 309 REMARK 465 GLU A 310 REMARK 465 GLU A 311 REMARK 465 GLU A 312 REMARK 465 GLU A 313 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 HIS B 1 REMARK 465 MET B 2 REMARK 465 ALA B 3 REMARK 465 SER B 4 REMARK 465 MET B 5 REMARK 465 THR B 6 REMARK 465 GLY B 7 REMARK 465 GLY B 8 REMARK 465 GLN B 9 REMARK 465 GLN B 10 REMARK 465 MET B 11 REMARK 465 GLY B 12 REMARK 465 ARG B 13 REMARK 465 GLY B 14 REMARK 465 SER B 15 REMARK 465 GLU B 16 REMARK 465 ASP B 17 REMARK 465 GLU B 303 REMARK 465 GLU B 304 REMARK 465 GLN B 305 REMARK 465 GLN B 306 REMARK 465 ARG B 307 REMARK 465 GLU B 308 REMARK 465 LEU B 309 REMARK 465 GLU B 310 REMARK 465 GLU B 311 REMARK 465 GLU B 312 REMARK 465 GLU B 313 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 19 CG CD1 CD2 REMARK 470 LYS A 21 CG CD CE NZ REMARK 470 SER A 49 OG REMARK 470 GLU A 61 CG CD OE1 OE2 REMARK 470 LYS A 69 CG CD CE NZ REMARK 470 LYS A 261 NZ REMARK 470 ARG A 301 NH1 NH2 REMARK 470 GLU A 303 CG CD OE1 OE2 REMARK 470 GLU A 304 CG CD OE1 OE2 REMARK 470 GLN A 305 CG CD OE1 NE2 REMARK 470 ARG A 307 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 21 CG CD CE NZ REMARK 470 GLN B 22 OE1 NE2 REMARK 470 GLU B 24 CG CD OE1 OE2 REMARK 470 GLU B 31 CD OE1 OE2 REMARK 470 ARG B 141 CG CD NE CZ NH1 NH2 REMARK 470 MET B 175 CG SD CE REMARK 470 GLN B 265 OE1 NE2 REMARK 470 ARG B 301 NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 92 -126.65 58.86 REMARK 500 ARG A 145 -5.49 81.51 REMARK 500 GLU A 195 17.08 80.80 REMARK 500 LEU B 30 -151.19 -115.68 REMARK 500 TYR B 38 1.90 81.66 REMARK 500 ASN B 92 -134.73 56.08 REMARK 500 ARG B 145 -5.45 81.92 REMARK 500 ASN B 199 -151.10 -120.07 REMARK 500 TYR B 221 5.42 81.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5BS A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5BS B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 402 DBREF 5DH3 A 15 313 UNP Q13188 STK3_HUMAN 15 313 DBREF 5DH3 B 15 313 UNP Q13188 STK3_HUMAN 15 313 SEQADV 5DH3 GLY A -1 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 SER A 0 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 HIS A 1 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 MET A 2 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 ALA A 3 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 SER A 4 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 MET A 5 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 THR A 6 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLY A 7 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLY A 8 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLN A 9 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLN A 10 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 MET A 11 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLY A 12 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 ARG A 13 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLY A 14 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLY B -1 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 SER B 0 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 HIS B 1 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 MET B 2 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 ALA B 3 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 SER B 4 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 MET B 5 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 THR B 6 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLY B 7 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLY B 8 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLN B 9 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLN B 10 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 MET B 11 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLY B 12 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 ARG B 13 UNP Q13188 EXPRESSION TAG SEQADV 5DH3 GLY B 14 UNP Q13188 EXPRESSION TAG SEQRES 1 A 315 GLY SER HIS MET ALA SER MET THR GLY GLY GLN GLN MET SEQRES 2 A 315 GLY ARG GLY SER GLU ASP SER LEU THR LYS GLN PRO GLU SEQRES 3 A 315 GLU VAL PHE ASP VAL LEU GLU LYS LEU GLY GLU GLY SER SEQRES 4 A 315 TYR GLY SER VAL PHE LYS ALA ILE HIS LYS GLU SER GLY SEQRES 5 A 315 GLN VAL VAL ALA ILE LYS GLN VAL PRO VAL GLU SER ASP SEQRES 6 A 315 LEU GLN GLU ILE ILE LYS GLU ILE SER ILE MET GLN GLN SEQRES 7 A 315 CYS ASP SER PRO TYR VAL VAL LYS TYR TYR GLY SER TYR SEQRES 8 A 315 PHE LYS ASN THR ASP LEU TRP ILE VAL MET GLU TYR CYS SEQRES 9 A 315 GLY ALA GLY SER VAL SER ASP ILE ILE ARG LEU ARG ASN SEQRES 10 A 315 LYS THR LEU ILE GLU ASP GLU ILE ALA THR ILE LEU LYS SEQRES 11 A 315 SER THR LEU LYS GLY LEU GLU TYR LEU HIS PHE MET ARG SEQRES 12 A 315 LYS ILE HIS ARG ASP ILE LYS ALA GLY ASN ILE LEU LEU SEQRES 13 A 315 ASN THR GLU GLY HIS ALA LYS LEU ALA ASP PHE GLY VAL SEQRES 14 A 315 ALA GLY GLN LEU THR ASP TPO MET ALA LYS ARG ASN TPO SEQRES 15 A 315 VAL ILE GLY THR PRO PHE TRP MET ALA PRO GLU VAL ILE SEQRES 16 A 315 GLN GLU ILE GLY TYR ASN CYS VAL ALA ASP ILE TRP SER SEQRES 17 A 315 LEU GLY ILE THR SER ILE GLU MET ALA GLU GLY LYS PRO SEQRES 18 A 315 PRO TYR ALA ASP ILE HIS PRO MET ARG ALA ILE PHE MET SEQRES 19 A 315 ILE PRO THR ASN PRO PRO PRO THR PHE ARG LYS PRO GLU SEQRES 20 A 315 LEU TRP SER ASP ASP PHE THR ASP PHE VAL LYS LYS CYS SEQRES 21 A 315 LEU VAL LYS ASN PRO GLU GLN ARG ALA THR ALA THR GLN SEQRES 22 A 315 LEU LEU GLN HIS PRO PHE ILE LYS ASN ALA LYS PRO VAL SEQRES 23 A 315 SER ILE LEU ARG ASP LEU ILE THR GLU ALA MET GLU ILE SEQRES 24 A 315 LYS ALA LYS ARG HIS GLU GLU GLN GLN ARG GLU LEU GLU SEQRES 25 A 315 GLU GLU GLU SEQRES 1 B 315 GLY SER HIS MET ALA SER MET THR GLY GLY GLN GLN MET SEQRES 2 B 315 GLY ARG GLY SER GLU ASP SER LEU THR LYS GLN PRO GLU SEQRES 3 B 315 GLU VAL PHE ASP VAL LEU GLU LYS LEU GLY GLU GLY SER SEQRES 4 B 315 TYR GLY SER VAL PHE LYS ALA ILE HIS LYS GLU SER GLY SEQRES 5 B 315 GLN VAL VAL ALA ILE LYS GLN VAL PRO VAL GLU SER ASP SEQRES 6 B 315 LEU GLN GLU ILE ILE LYS GLU ILE SER ILE MET GLN GLN SEQRES 7 B 315 CYS ASP SER PRO TYR VAL VAL LYS TYR TYR GLY SER TYR SEQRES 8 B 315 PHE LYS ASN THR ASP LEU TRP ILE VAL MET GLU TYR CYS SEQRES 9 B 315 GLY ALA GLY SER VAL SER ASP ILE ILE ARG LEU ARG ASN SEQRES 10 B 315 LYS THR LEU ILE GLU ASP GLU ILE ALA THR ILE LEU LYS SEQRES 11 B 315 SER THR LEU LYS GLY LEU GLU TYR LEU HIS PHE MET ARG SEQRES 12 B 315 LYS ILE HIS ARG ASP ILE LYS ALA GLY ASN ILE LEU LEU SEQRES 13 B 315 ASN THR GLU GLY HIS ALA LYS LEU ALA ASP PHE GLY VAL SEQRES 14 B 315 ALA GLY GLN LEU THR ASP TPO MET ALA LYS ARG ASN TPO SEQRES 15 B 315 VAL ILE GLY THR PRO PHE TRP MET ALA PRO GLU VAL ILE SEQRES 16 B 315 GLN GLU ILE GLY TYR ASN CYS VAL ALA ASP ILE TRP SER SEQRES 17 B 315 LEU GLY ILE THR SER ILE GLU MET ALA GLU GLY LYS PRO SEQRES 18 B 315 PRO TYR ALA ASP ILE HIS PRO MET ARG ALA ILE PHE MET SEQRES 19 B 315 ILE PRO THR ASN PRO PRO PRO THR PHE ARG LYS PRO GLU SEQRES 20 B 315 LEU TRP SER ASP ASP PHE THR ASP PHE VAL LYS LYS CYS SEQRES 21 B 315 LEU VAL LYS ASN PRO GLU GLN ARG ALA THR ALA THR GLN SEQRES 22 B 315 LEU LEU GLN HIS PRO PHE ILE LYS ASN ALA LYS PRO VAL SEQRES 23 B 315 SER ILE LEU ARG ASP LEU ILE THR GLU ALA MET GLU ILE SEQRES 24 B 315 LYS ALA LYS ARG HIS GLU GLU GLN GLN ARG GLU LEU GLU SEQRES 25 B 315 GLU GLU GLU MODRES 5DH3 TPO A 174 THR MODIFIED RESIDUE MODRES 5DH3 TPO A 180 THR MODIFIED RESIDUE MODRES 5DH3 TPO B 174 THR MODIFIED RESIDUE MODRES 5DH3 TPO B 180 THR MODIFIED RESIDUE HET TPO A 174 11 HET TPO A 180 11 HET TPO B 174 11 HET TPO B 180 11 HET 5BS A 401 28 HET CL A 402 1 HET 5BS B 401 28 HET SO4 B 402 5 HETNAM TPO PHOSPHOTHREONINE HETNAM 5BS 4-[(5,10-DIMETHYL-6-OXO-6,10-DIHYDRO-5H-PYRIMIDO[5,4- HETNAM 2 5BS B]THIENO[3,2-E][1,4]DIAZEPIN-2-YL) HETNAM 3 5BS AMINO]BENZENESULFONAMIDE HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 4(C4 H10 N O6 P) FORMUL 3 5BS 2(C17 H16 N6 O3 S2) FORMUL 4 CL CL 1- FORMUL 6 SO4 O4 S 2- FORMUL 7 HOH *128(H2 O) HELIX 1 AA1 GLN A 22 VAL A 26 1 5 HELIX 2 AA2 ASP A 63 CYS A 77 1 15 HELIX 3 AA3 VAL A 107 ASN A 115 1 9 HELIX 4 AA4 ILE A 119 MET A 140 1 22 HELIX 5 AA5 LYS A 148 GLY A 150 5 3 HELIX 6 AA6 THR A 184 MET A 188 5 5 HELIX 7 AA7 ALA A 189 GLU A 195 1 7 HELIX 8 AA8 VAL A 201 GLY A 217 1 17 HELIX 9 AA9 HIS A 225 ASN A 236 1 12 HELIX 10 AB1 SER A 248 LEU A 259 1 12 HELIX 11 AB2 THR A 268 HIS A 275 1 8 HELIX 12 AB3 HIS A 275 ASN A 280 1 6 HELIX 13 AB4 PRO A 283 ILE A 286 5 4 HELIX 14 AB5 LEU A 287 ARG A 307 1 21 HELIX 15 AB6 GLN B 22 VAL B 26 1 5 HELIX 16 AB7 ASP B 63 CYS B 77 1 15 HELIX 17 AB8 VAL B 107 ASN B 115 1 9 HELIX 18 AB9 ILE B 119 MET B 140 1 22 HELIX 19 AC1 LYS B 148 GLY B 150 5 3 HELIX 20 AC2 THR B 184 MET B 188 5 5 HELIX 21 AC3 ALA B 189 GLN B 194 1 6 HELIX 22 AC4 VAL B 201 GLY B 217 1 17 HELIX 23 AC5 HIS B 225 ASN B 236 1 12 HELIX 24 AC6 SER B 248 LEU B 259 1 12 HELIX 25 AC7 THR B 268 GLN B 274 1 7 HELIX 26 AC8 HIS B 275 ASN B 280 1 6 HELIX 27 AC9 PRO B 283 ILE B 286 5 4 HELIX 28 AD1 LEU B 287 HIS B 302 1 16 SHEET 1 AA1 5 PHE A 27 GLU A 35 0 SHEET 2 AA1 5 SER A 40 HIS A 46 -1 O VAL A 41 N GLY A 34 SHEET 3 AA1 5 GLN A 51 PRO A 59 -1 O ILE A 55 N PHE A 42 SHEET 4 AA1 5 ASP A 94 GLU A 100 -1 O LEU A 95 N VAL A 58 SHEET 5 AA1 5 TYR A 85 LYS A 91 -1 N GLY A 87 O VAL A 98 SHEET 1 AA2 3 GLY A 105 SER A 106 0 SHEET 2 AA2 3 ILE A 152 LEU A 154 -1 O LEU A 154 N GLY A 105 SHEET 3 AA2 3 ALA A 160 LEU A 162 -1 O LYS A 161 N LEU A 153 SHEET 1 AA3 2 LYS A 142 ILE A 143 0 SHEET 2 AA3 2 GLY A 169 GLN A 170 -1 O GLY A 169 N ILE A 143 SHEET 1 AA4 5 PHE B 27 GLY B 36 0 SHEET 2 AA4 5 GLY B 39 HIS B 46 -1 O LYS B 43 N LEU B 30 SHEET 3 AA4 5 VAL B 52 VAL B 58 -1 O ILE B 55 N PHE B 42 SHEET 4 AA4 5 ASP B 94 GLU B 100 -1 O MET B 99 N ALA B 54 SHEET 5 AA4 5 TYR B 85 LYS B 91 -1 N GLY B 87 O VAL B 98 SHEET 1 AA5 3 GLY B 105 SER B 106 0 SHEET 2 AA5 3 ILE B 152 LEU B 154 -1 O LEU B 154 N GLY B 105 SHEET 3 AA5 3 ALA B 160 LEU B 162 -1 O LYS B 161 N LEU B 153 SHEET 1 AA6 2 LYS B 142 ILE B 143 0 SHEET 2 AA6 2 GLY B 169 GLN B 170 -1 O GLY B 169 N ILE B 143 LINK C ASP A 173 N TPO A 174 1555 1555 1.33 LINK C TPO A 174 N MET A 175 1555 1555 1.33 LINK C ASN A 179 N TPO A 180 1555 1555 1.33 LINK C TPO A 180 N VAL A 181 1555 1555 1.33 LINK C ASP B 173 N TPO B 174 1555 1555 1.32 LINK C TPO B 174 N MET B 175 1555 1555 1.33 LINK C ASN B 179 N TPO B 180 1555 1555 1.33 LINK C TPO B 180 N VAL B 181 1555 1555 1.33 SITE 1 AC1 9 LEU A 33 GLU A 100 TYR A 101 CYS A 102 SITE 2 AC1 9 GLY A 103 GLY A 105 ASP A 109 LEU A 153 SITE 3 AC1 9 ASP A 164 SITE 1 AC2 1 LYS A 132 SITE 1 AC3 11 LEU B 33 VAL B 41 ALA B 54 GLU B 100 SITE 2 AC3 11 TYR B 101 CYS B 102 ASP B 109 LEU B 153 SITE 3 AC3 11 ALA B 163 LYS B 298 HOH B 525 SITE 1 AC4 4 CYS B 102 GLY B 103 ASN B 155 THR B 156 CRYST1 89.871 98.462 166.771 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011127 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010156 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005996 0.00000